Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA
- PMID: 8362987
- PMCID: PMC1887222
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA
Abstract
Hepatocyte growth factor, also known as scatter factor, is a complete mitogen for hepatocytes that bears sequence and structural homology with plasminogen. Because it exists in both a mitogenically inactive single-chain form and an active two-chain form, we were interested in determining whether plasminogen activators could properly cleave single-chain hepatocyte growth factor to generate active two-chain hepatocyte growth factor. Herein we report that both urokinase-type plasminogen activator and tissue-type plasminogen activator can cleave single-chain hepatocyte growth factor, generating two-chain hepatocyte growth factor. When equal quantities of plasminogen activator-treated and activator-untreated hepatocyte growth factor are compared in serum-free in vitro bioassays, the treated hepatocyte growth factor is mitotically more active. Also, urokinase-type plasminogen activator was inactive against hepatocyte growth factor molecules with a mutated cleavage site. This suggests that urokinase-type and tissue-type plasminogen activator may be natural biological regulators of hepatocyte growth factor. Because the active form of hepatocyte growth factor is a powerful stimulator of DNA synthesis and cell motility, these findings may be relevant in understanding the role of plasminogen activators in the biology of cancer invasion and metastasis.
Similar articles
-
Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.Cancer Res. 1996 Jun 15;56(12):2837-43. Cancer Res. 1996. PMID: 8665523
-
Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.Hepatology. 2007 Jun;45(6):1527-37. doi: 10.1002/hep.21613. Hepatology. 2007. PMID: 17538930
-
HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.Mod Pathol. 2003 Jan;16(1):14-21. doi: 10.1097/01.MP.0000043521.96995.DB. Mod Pathol. 2003. PMID: 12527708
-
Cellular receptors for the plasminogen activators.Blood. 1994 Jun 15;83(12):3427-36. Blood. 1994. PMID: 8204869 Review. No abstract available.
-
Regulation of the pericellular activation of plasminogen and its role in tissue-destructive processes.Acta Ophthalmol Suppl (1985). 1992;(202):34-41. doi: 10.1111/j.1755-3768.1992.tb02166.x. Acta Ophthalmol Suppl (1985). 1992. PMID: 1322009 Review. No abstract available.
Cited by
-
Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods.Int J Retina Vitreous. 2020 Jul 2;6:27. doi: 10.1186/s40942-020-00228-x. eCollection 2020. Int J Retina Vitreous. 2020. PMID: 32637155 Free PMC article.
-
Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1.Lab Invest. 2015 Oct;95(10):1117-29. doi: 10.1038/labinvest.2015.94. Epub 2015 Aug 3. Lab Invest. 2015. PMID: 26237273 Free PMC article.
-
Tissue Plasminogen Activator: Side Effects and Signaling.J Drug Des Res. 2014 Sep 25;1(1):1001. J Drug Des Res. 2014. PMID: 25879083 Free PMC article. No abstract available.
-
Role of HGF/c-Met in serum-starved ARPE-19 cells.Korean J Ophthalmol. 2007 Dec;21(4):244-50. doi: 10.3341/kjo.2007.21.4.244. Korean J Ophthalmol. 2007. PMID: 18063891 Free PMC article.
-
Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.J Gastroenterol. 2002 Nov;37 Suppl 14:15-21. doi: 10.1007/BF03326408. J Gastroenterol. 2002. PMID: 12572861 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous